Masimo can still appeal the US International Trade Commission's decision to not pursue another import ban on the Apple Watch.
Get Nizam's Institute of Medical Sciences News on Telangana Today, Nizam's Institute of Medical Sciences latest news, Nizam's Institute of Medical Sciences news, | Telangana Today ...
St. Luke's University Health Network is marking a decade of leadership and transformation in patient safety through its innovative use of Masimo continuous monitoring technology, an advancement that ...
What just happened? Apple's latest Apple Watch redesign has cleared a key hurdle at a US trade agency, easing one immediate threat to its wearable roadmap while leaving a broader, high-stakes patent ...
Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge ...
A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...
Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation (Danaher). Under the ...
Danaher Corporation, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider ...
The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...
In this week’s edition of InnovationRx, we look at Danaher’s $10 billion acquisition of Masimo, Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in ...
Masimo stock (MASI) has faced a challenging year, trailing the broader market with a -3% annual return. While shares surged 34% yesterday following news of an acquisition by Danaher, this spike only ...
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results